The YieldMax MRNA Option Income Strategy ETF (MRNY) is an actively managed ETF launched on October 24, 2023, designed to generate monthly income through a synthetic covered call strategy. It provides indirect exposure to Moderna, Inc. (MRNA) stock, using options contracts to collect premiums while capping potential gains. Distributions are paid monthly, with a high yield (e.g., 157.72% as of August 2025), though subject to market volatility and risks.
Advertisement
Invest wisely. Past performance is not indicative of future results.
